drugset / Trial / NCT01193140
To Evaluate the Safety of Veliparib in Combination With Temozolomide in Subjects With Solid Tumors
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To evaluate the safety and tolerability of the veliparib/TMZ combination in subjects with solid tumors.
Timeline
- Start
- 2010-07
- Primary completion
- 2011-11
- Completion
- 2011-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Temozolomide | Small molecule | — | Oral |
| Subject | Veliparib | Small molecule | — | Oral |
Indications
No indication recorded.